Exp Clin Endocrinol Diabetes 2018; 126(07): 429-436
DOI: 10.1055/s-0043-117417
Article
© Georg Thieme Verlag KG Stuttgart · New York

Gender and Age Differences in Lipid Profile Among Chinese Adults in Nanjing: a Retrospective Study of Over 230,000 Individuals from 2009 to 2015

Tianwei Gu*
1   Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing, China
,
Weihong Zhou*
2   Health Manager Center, Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing, China
,
Jie Sun*
1   Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing, China
,
Jing Wang
2   Health Manager Center, Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing, China
,
Dalong Zhu
1   Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing, China
,
Yan Bi
1   Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School, Nanjing, China
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 27. Mai 2017
first decision 19. Juli 2017

accepted 24. Juli 2017

Publikationsdatum:
11. September 2017 (online)

Abstract

Background Previous national survey suggested that dyslipidemia is an increasing burden in China and more severe in urban population. In this study, we retrospectively analyzed the gender and age differences in lipids and lipoproteins in a large Chinese urban population in Nanjing city.

Methods A total of 236, 945 adults (age ≥20 years old) who undertook a health check between 2009 and 2015 in our medical examination center were involved in the analysis. Fasting total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol and triglyceride (TG) were measured by standard methods.

Results The age-standardized estimates of serum total cholesterol, HDL cholesterol, LDL cholesterol and triglyceride were 4.77 (4.76–4.79), 1.19 (1.18–1.19), 2.53 (2.52–2.54) and 1.74 (1.72–1.76) mmol/L in males (n=130954), and 4.79 (4.78–4.80), 1.46 (1.45–1.46), 2.44 (2.43–2.45) and 1.21 (1.19–1.22) mmol/L in females (n=105991), respectively. The prevalence of dyslipidemia was significantly elevated in females above 50 years old, and the peak prevalence of dyslipidemia in males was in the age group of 40–59 years, earlier as compared to females (peaked at 60–69 years old). In addition, an increasing secular trend was observed in LDL cholesterol levels from 2009 to 2015 in both males and females.

Conclusions Dyslipidemia is an increasing epidemic in China, characterized by a rising trend of LDL cholesterol. The gender and age differences in serum levels of lipid profile as well as prevalence of dyslipidemia suggested that the middle-age men and postmenopausal women should be the prioritized target for better control of dyslipidemia and early prevention of cardiovascular disease.

* These authors contributed equally to this study.


Supplementary Material

 
  • References

  • 1 Wilson PW, Garrison RJ, Castelli WP. et al. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol [Internet] 1980; 46: 649-54
  • 2 Stamler J, Daviglus ML, Garside DB. et al. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000; 284: 311-8
  • 3 Gordon T, Castelli WP, Hjortland MC. et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med [Internet] 1977; 62: 707-14
  • 4 He J, Gu D, Wu X. et al. Major causes of death among men and women in China. N Engl J Med. 2005; 353: 1124-34
  • 5 Carroll MD, Lacher DA, Sorlie PD. et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005; 294: 1773-81
  • 6 Carroll MD, Kit BK, Lacher DA. et al. Trends in lipids and lipoproteins in us Adults, 1988-2010. JAMA 2012; 308: 1545-54
  • 7 He J, Gu D, Reynolds K. et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004; 110: 405-11
  • 8 Yang W, Xiao J, Yang Z. et al. Serum lipids and lipoproteins in chinese men and women. Circulation 2012; 125: 2212-21
  • 9 Jia W, Xiang K, Chen L. et al. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev [Internet] 2002; 3: 157-65
  • 10 Wilson PW, D’Agostino RB, Levy D. et al. Prediction of coronary heart disease using risk factor categories. Circulation [Internet] 1998; 97: 1837-47
  • 11 National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult TreatmentPanel III) . Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421
  • 12 Jacobson TA, Maki KC, Orringer CE. et al. National lipid association recommendations for patient-centered management of dyslipidemia: Part 2. J Clin Lipidol 2015; 9: S1-122
  • 13 Karita K, Yamanouchi Y, Takano T. et al. Associations of blood selenium and serum lipid levels in Japanese premenopausal and postmenopausal women. Menopause [Internet] 2008; 15: 119-24
  • 14 Cagnacci A, Cannoletta M, Palma F. et al. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. Climacteric 2012; 15: 157-62
  • 15 Poehlman ET, Toth MJ, Ades PA. et al. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest. 1997; 27: 322-6
  • 16 Gordon DJ, Probstfield JL, Garrison RJ. et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15
  • 17 Gotto Jr. AM, Brinton EA. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol [Internet] 2004; 43: 717-24
  • 18 Schreiner PJ, Jacobs DRJ, Wong ND. et al. Twenty-five year secular trends in lipids and modifiable risk factors in a population-based biracial cohort: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2011. J Am Heart Assoc 2016; 5: 1-12
  • 19 Gupta R, Guptha S, Agrawal A. et al. Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population. Lipids Health Dis [Internet] 2008; 7: 40
  • 20 Iso H.. Changes in coronary heart disease risk among Japanese. Circulation 2008; 118: 2725-9
  • 21 Casagrande SS, Fradkin JE, Saydah SH. et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013; 36: 2271-9
  • 22 Ji L, Hu D, Pan C. et al. Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients. Am J Med [Internet] 2013; 126: 925.e11-22
  • 23 Xu T, Zhu G, Han S.. Trend of body compositions with aging among chinese adolescents, adults and elders. J Nutr Health Aging [Internet] 2015
  • 24 Wan Y, Jiang X, He Y. et al. Body Mass Index of Young Men in China. Medicine (Baltimore) [Internet] 2016; 95: e2829